Quantum Molecular Resonance to Treat Neuropathic Corneal Pain and Regrow Corneal Nerves
Official title: Efficacy of Quantum Molecular Resonance in Neuropathic Corneal Pain and Corneal Nerve Regeneration
Run by Singapore Eye Research Institute · NCT07174739 · Data updated 2026-11-12
This study will try Quantum Molecular Resonance (QMR) to reduce eye pain and promote corneal nerve regrowth in adults with neuropathic corneal pain.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Singapore Eye Research Institute Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Singapore) |
| Status | Recruiting |
| Started | November 1, 2023 |
| Main results expected | October 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | September 19, 2025 |
| Trial ID | NCT07174739 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 21 and older with diagnosed neuropathic corneal pain, minimal slit-lamp findings, and corneal nerve abnormalities on IVCM who can attend all study visits are ideal candidates.
✕Probably not a fit
Patients who are pregnant, have active implantable electronic devices, recent ocular surgery, active ocular infection or inflammation, or are undergoing cancer treatment are excluded and unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with neuropathic corneal pain will attend nine visits including one baseline assessment and eight QMR treatment sessions using a Rexon-Eye device. At each visit participants will undergo ocular surface exams, in vivo confocal microscopy to measure corneal nerve morphology, tear protein collection, and symptom and quality-of-life questionnaires. Investigators will compare pain scores, corneal nerve metrics, ocular surface findings, and tear biomarkers before and after the QMR treatment course. The study team hypothesizes that repeated QMR sessions will reduce pain, stimulate corneal nerve regeneration, and improve patient-reported quality of life.
Why it matters
Potential benefit: If successful, QMR could reduce chronic eye pain, improve corneal nerve structure, and enhance daily functioning and quality of life for affected patients.
How similar studies have gone: Small studies of QMR/Rexon-Eye in dry eye populations have reported symptom improvements, but rigorous evidence for use in neuropathic corneal pain is limited and relatively untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Be at least 21 years of age. * Regardless of gender (Male/Female). * Regardless of race (Chinese/Malay/Indian/Eurasian/Others). * Diagnosed with neuropathic corneal pain based on the following criteria: presence of neuropathic ocular symptoms (burning, stinging, photophobia, pain, severe dryness), absent or minimal slit-lamp findings to explain the symptoms and corneal nerve abnormalities as detected by IVCM (decreased corneal length and density, presence of neuromas). * Willing to receive all eye examinations in this study. Exclusion Criteria: * Pregnant women. * Participants carrying active implantable devices (e.g., pacemakers and hearing aids). * Oncologic patients under treatment; patient who underwent ocular surgery in the last month. * Participants who had ocular infection within 6 months, or active ocular infection or inflammation; any concomitant ocular diseases that could potentially induce ocular pain, such as uveitis.
Where it's running
-
Singapore National Eye Centre
Singapore, Singapore Recruiting
Study contacts
- Study coordinator: Yu-Chi Liu, MD, MCI, PhD
- Email: liu.yu.chi@snec.com.sg
- Phone: 65 65767287
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Neuropathic Pain Severity in Lumbar Spinal Stenosis and Its Link to Radiology
This study will test how severe neuropathic pain is in adults with lumbar spinal stenosis and see if it relates to MRI findings and other clinical features.
-
Virtual Reality-Based Hypnotherapy to Help Pain, Sleep, and Mood in Spinal Cord Injury
Adults with spinal cord injury will try adding short VR-based hypnotherapy sessions to their standard physiotherapy to see if it reduces pain and improves sleep and mood.
-
Extended-release Pregabalin for nerve pain from diabetes or shingles
This phase 3 study tests an extended-release form of pregabalin to see if it reduces nerve-pain symptoms in adults with diabetic neuropathy or postherpetic neuralgia.
-
High-Intensity Peripheral Magnetic Stimulation for Traumatic Nerve Injury
This study tests whether adding high-intensity peripheral magnetic stimulation to a structured exercise program can reduce pain and improve function for adults with a traumatic peripheral nerve injury.
-
Hematological clues and how patients respond to nerve blocks for neuropathic pain
This study looks at blood inflammation markers to see if they relate to how well people with neuropathic pain respond to sympathetic nerve blocks.
-
Cord plasma eye drops to treat neuropathic corneal pain
This trial will test whether cord plasma eye drops can reduce long-lasting nerve-related corneal pain in people with evidence of corneal nerve damage.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.